VIR BIOTECHNOLOGY
Vir Biotechnology is a commercial-stage immunology company developing therapeutic products to treat and prevent serious infectious diseases. The company brings together cutting-edge innovations with scientific expertise and management. It seeks to take a new approach, using breakthroughs in immune programming to manipulate pathogen-host interactions. Vir Biotechnology also focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases.... The company four current technology platforms are designed to, either individually or in combination, stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Their vision is that one day, diseases like hepatitis B, influenza A, HIV, and tuberculosis become a thing of the past.
VIR BIOTECHNOLOGY
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-04-07
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.vir.bio
Total Employee:
501+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
908.6 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Tag Manager Google Analytics Content Delivery Network Amazon Global Site Tag IPv6
Similar Organizations
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Flightpath Biosciences
Flightpath Biosciences is a biotechnology company that develops medications to treat rare infectious diseases.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Q32 Bio
Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-05-10 | Agenovir Corporation | Agenovir Corporation acquired by Vir Biotechnology | N/A |
| 2017-09-25 | Humabs | Humabs acquired by Vir Biotechnology | N/A |
| 2017-01-06 | TomegaVax | TomegaVax acquired by Vir Biotechnology | N/A |
Investors List
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - Vir Biotechnology
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Grant - Vir Biotechnology
GlaxoSmithKline
GlaxoSmithKline investment in Post-IPO Equity - Vir Biotechnology
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Vir Biotechnology
Alta Partners
Alta Partners investment in Series B - Vir Biotechnology
SoftBank Vision Fund
SoftBank Vision Fund investment in Series B - Vir Biotechnology
Alta Partners
Alta Partners investment in Venture Round - Vir Biotechnology
ARCH Venture Partners
ARCH Venture Partners investment in Venture Round - Vir Biotechnology
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation investment in Venture Round - Vir Biotechnology
SoftBank Vision Fund
SoftBank Vision Fund investment in Venture Round - Vir Biotechnology
Key Employee Changes
Official Site Inspections
http://www.vir.bio Semrush global rank: 2.59 M Semrush visits lastest month: 6.98 K
- Host name: ec2-54-176-110-96.us-west-1.compute.amazonaws.com
- IP address: 54.176.110.96
- Location: San Jose United States
- Latitude: 37.3388
- Longitude: -121.8914
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 95141
More informations about "Vir Biotechnology"
Vir Biotechnology - EverybodyWiki Bios & Wiki
History. Vir Biotechnology was founded in 2016 and successfully completed a round of financing exceeding US$500 million. Shortly after this event, Vir announced it would acquire Humabs โฆSee details»
Our Leadership | Vir Biotechnology
Vir Biotechnology, Inc. 1800 Owens Street Suite 900 San Francisco, CA 94158See details»
Vir Biotechnology, Inc. - Investor Relations
Mar 4, 2025 IR Contact. Vir Biotechnology, Inc. 1800 Owens St., Suite 900 San Francisco, CA 94158. contact us by phone 415-906-4324 [email protected]. Follow us. opens in a new windowSee details»
Vir Biotechnology - Crunchbase Company Profile
Vir Biotechnology also focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The โฆSee details»
Our Development Pipeline | Vir Biotechnology
Tobevibart + elebsiran ± PEG-IFN-ฮฑ. Treatment. Alnylam. Collaborator: Alnylam Treatment Type: Treatment Phase: Phase 2,75%See details»
Vir Biotechnology, Inc. (VIR) Company Profile & Facts - Yahoo โฆ
See the company profile for Vir Biotechnology, Inc. (VIR) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Vir Biotechnology, Inc. - Vir Biotechnology Provides Corporate โฆ
3 days ago A live webcast will be available on https://investors.vir.bio and will be archived for 30 days. About VIR-5818, VIR-5500, VIR-5525. VIR-5818, VIR-5500 and VIR-5525 are โฆSee details»
Vir Biotechnology, Inc. (formerly Humabs BioMed AG)
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on engineering antibodies into impactful medicines to treat infectious diseases and cancer. Since 2025, Humabs BioMed AG (acquired by Vir Biotechnology in โฆSee details»
Vir Leans Into Immunology Roots After Flamed-Out โฆ
Feb 12, 2025 Vir signed a deal with Sanofi in August 2024 to bring in three masked T cell engagers, which also included about 50 people well versed in what the assets could do, de Backer said. โThat was a great fit for our company to โฆSee details»
Vir Biotechnology (VIR) Company Profile & Description - Stock โฆ
Oct 11, 2019 Vir Biotechnology, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutic products to treat and prevent serious infectious diseases in the United โฆSee details»
VIR Company Profile | Management and Employees List - Datanyze
VIR Profile and History Vir Biotechnology is a clinical-stage immunology company that focuses on combining immunologic insights with technologies to treat and prevent serious infectious โฆSee details»
Vir Biotechnology Provides Corporate Update and Reports First โฆ
3 days ago SAN FRANCISCO, May 07, 2025--Vir Biotechnology, Inc. (Nasdaq: VIR), today provided a corporate update and reported financial results for the first quarter ended March 31, โฆSee details»
Vir Biotechnology Announces Preliminary 24-Week Post-End of โฆ
1 day ago Vir Biotechnology (VIR) has announced 24-week post-treatment data from the MARCH Phase 2 study evaluating tobevibart and elebsiran combinations for chronic hepatitis โฆSee details»
Vir Biotechnology
Apr 26, 2025 It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the โฆSee details»
A Brief History of Vir Biotechnology โ CanvasBusinessModel.com
Nov 11, 2024 2018: Vir Biotechnology forms strategic partnerships with leading academic institutions and pharmaceutical companies. 2019: The company advances several promising โฆSee details»
Our Strategy | Vir Biotechnology
Vir Biotechnology has built a strong foundation based on cutting-edge core scientific capabilities and a world-class team of experts who bring unmatched knowledge and experience to our โฆSee details»
Vir Biotechnology, Inc. (VIR) - Yahoo Finance Canada
See the company profile for Vir Biotechnology, Inc. (VIR) including business summary, industry/sector information, number of employees, business summary, corporate governance, โฆSee details»
Our Board of Directors | Vir Biotechnology
Vir Biotechnology, Inc. 1800 Owens Street Suite 900 San Francisco, CA 94158See details»
Vir Biotechnology, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 7, 2025 Group 3 will enroll approximately 8 participants randomized into Cohort 3a or Cohort 3b. Cohort 3a will receive the high dose prime VRON-0200 vaccination of vector AdC7 โฆSee details»
Working At Vir Biotechnology: Company Overview and Culture
Mar 14, 2024 www.vir.bio. Organization Type. Public. Social Media. Vir Biotechnology is a clinical-stage immunology company developing therapeutic products to treat and prevent โฆSee details»